Applications are evaluated based on four criteria:

  • Scientific merit
  • Innovation
  • Clinical and medical impact
  • Quality of research environment

Scientific merit

  • The validity of the rationale / proposed methodology
  • The validity of the expected outcomes
  • The validity of the proposed timelines
  • The feasibility of completing the proposed work within 18 months


  • Innovation in design, methodology and objectives

Clinical / medical impact

  • Contribution of the Research Project results to increase diagnosis and for clinical and scientific understanding
  • Improve disease management or develop novel concepts on immune thrombocytopenia (ITP)
  • Relevance of the project to the clinical practice for ITP
  • Increase knowledge of SYK inhibition in ITP or other diseases.


  • Team clinical/scientific expertise and experience
  • Qualification of the participants
  • Expertise in the academic/clinical research environment